Concentrations of interleukin-2 in the nasopharyngeal secretion of children with acute respiratory syncytial virus bronchiolitis

Jornal de Pediatria

Volumn 80, Issue 4, 2004, Pages 315-320

  Giugno, Katia M ^a,d   Machado, Denise C ^b   Amantéa, Ségio L ^a   Menna Barreto, Sérgio S ^c  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d NONE   (Brazil)

Author keywords

Acute viral bronchiolitis; Interleukin 2; Nasopharyngeal aspirates; Respiratory syncytial virus

Indexed keywords

HEMOGLOBIN; INTERLEUKIN 2; OXYGEN;

AGE DISTRIBUTION; ARTICLE; ARTIFICIAL VENTILATION; BLOOD LEVEL; CHI SQUARE TEST; CLINICAL FEATURE; COMMON COLD; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INFANT; INTERLEUKIN 2 BLOOD LEVEL; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NOSE OBSTRUCTION; NOSE SECRETION; OXYGEN SATURATION; OXYGEN THERAPY; PULSE OXIMETRY; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SAMPLE SIZE; SCORING SYSTEM; TACHYPNEA; VIRAL BRONCHIOLITIS; VIRUS DETECTION; WHEEZING; ACUTE DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; ISOLATION AND PURIFICATION; METABOLISM; MULTICENTER STUDY; NASOPHARYNX; NEWBORN; PRESCHOOL CHILD; SECRETION; VIROLOGY; VIRUS INFECTION;

ACUTE DISEASE; BRONCHIOLITIS, VIRAL; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-2; MALE; NASOPHARYNX; OXYGEN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 16644385654     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/1206     Document Type: Article

References (30)

1. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282:1440-6.
2. Rubin FM, Fischer GB. Características clínicas e da saturação transcutânea de oxigênio em lactentes hospitalizados com bronquiolite viral aguda. J Pediatr (Rio J). 2003;79:435-42.
3. Kimpen JLL, Heymans HSA. Respiratory syncytial virus: immunity and immune injury. Immunol Infect Dis. 1993;3:281-8.
4. Anderson LJ, Heilman CA. Protective and disease-enhancing immune responses to respiratory syncytial virus. J Infect Dis. 1995;171:1-7.
5. Simoes EAF, Estrany XC. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J. 2003;22:S13-20.
6. Welliver RC. Respiratory syncytial virus and other respiratory viruses. Pediatr Infect Dis J. 2003;22:S6-12.
7. Hall CB, McCarthy CA. Respiratory syncytial virus. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's Principles & Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000.
8. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000;161:1501-7.
9. Hussell T, Spender LC, Georgiou A, O'Garra A, Openshaw PJ. Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J Gen Virol. 1996;77:2447-55.
10. Kimpen JLL. Respiratory syncytial virus immunology. Pediatr Allergy Immunol. 1996;7 Suppl 9:S86-90.
11. Openshaw PJM, Dean GS, Culley FJ. Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches. Pediatr Infect Dis J. 2003;22:S58-65.
12. Martinez F. Viruses and atopic sensitization in the first years of life. Am J Respir Crit Care Med. 2000;162:S95-9.
13. Prince GA, Horswood RL, Chanock RM. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J Virol. 1985;55:517-20.
14. Ruuskanen O, Ogra PL. Respiratory syncytial virus. Curr Probl Pediatr. 1993;23:50-79.
15. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JT, et al. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. Am J Respir Crit Care Med. 2000;161:1518-23.
16. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JT, et al. Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur Respir J. 1999;14:144-9.
17. Joshi P, Kakakios A, Jayasekera J, Isaacs D. A comparison of IL-2 levels in nasopharyngeal ans endotracheal aspirates of babies with respiratory syncytial viral bronchiolitis. J Allergy Clin Immunol. 1998;102:618-20.
18. Jackson M, Scott R. Different patterns of cytokine introduction in cultures of respiratory syncytial (RS) virus-specific human TH cell lines following stimulating with RS virus and RS virus protein. J Med Virol. 1996;49:161-9.
19. Renzi PM, Turgeon JP, Yang JP, Drblik SP, Marcotte JE, Pedneault, et al. Cellular immunity is activated and a TH-2 response is associated with early wheezing in infants after bronchiolitis. J Pediatr. 1997;130:584-93.
20. Sheeran P, Jafri H, Carubelli C, Saavedra J, Johnson C, Krisher K, et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis. 1999;18:115-22.
21. Abu-Harb M, Bell F, Finn A, Rao WH, Nixon L, Shale D, et al. IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis. Eur Respir J. 1999;14:139-43.
22. Hornsleth A, Klug B, Nir M, Johansen J, Hansen KS, Christensen LS, et al. Severity of respiratory syncytial virus disease related to type and genotype of virus and to cytokine values in nasopharyngeal secretions. Pediatr Infect Dis J. 1998;17: 1114-21.
23. De Boeck K, Van der Aa N, Van Lierde S, Corbeel L, Eeckels R. Respiratory syncytial virus bronchiolitis: a double-blind dexametasone efficacy study. J Pediatr. 1997;131:919-21.
24. Simoes EA. Respiratory syncytial virus infection. Lancet. 1999;354:847-52.
25. Behtendt CE, Decker MD, Burch DJ, Watson PH. International variation in the management of infants hospitalized with respiratory syncytial virus. Eur J Pediatr. 1998;157:215-20.
26. Wang EEL, Law BJ, Boucher FD, Stephens D, Robinson JL, Dobson S, et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial virus lower respiratory tract infection. J Pediatr. 1995;126:212-9.
27. Wang EEL, Law BJ, Boucher FD, Stephens D, Robinson JL, Dobson S, et al. Pediatric Investigators Collaborative Network in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1996;129:390-5.
28. Rodriguez WJ, Gruber WC, Groothuis JR, Simoes EAF, Rosas AJ, Lepow M, et al. RSV-IGIV Study Group. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. Pediatrics. 1997;100: 937-42.
29. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143:S127-32.
30. Villar J, Flores C, Méndez-Alvarez S. Genetic susceptibility to acute lung injury. Crit Care Med. 2003;31:S272-75.